European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Market report

Oncology drug tenders in Portugal — market report, November 2025

Oncology drug tenders in Portugal in November 2025: 328 tenders published (+70% month on month, +43% year on year), estimated at €348,000 in total, and 317 contracts awarded (+63% month on month, -18% year on year), worth €2,647,343 (awarded value). Buyers with the most tenders: Unidade Local de Saúde de Trás-os-Montes e Alto Douro, E. P. E. (45), Unidade Local de Saúde de Santo António, E. P. E. (26) and Unidade Local de Saúde da Região de Aveiro, E. P. E. (20); most contracts won: Generis – Farmaceutica, S.A. (22), Teva Pharma - Produtos Farmaceuticos,lda (16) and Novartis Farma-Prod.farmacêuticos,sa. (13). On average 11.4 bids per contract; 9% of contracts had a single bid. Report made on 27 October 2026.

Tenders published
328
Contracts awarded
317
Contract value awarded
€2,647,343
Bids per contract
11.4
Tenders published per month
05001K1.5KNov 24: 230Nov 24: 230Nov 24Dec 24: 967Dec 24: 967Dec 24Jan 25: 1,160Jan 25: 1,160Jan 25Feb 25: 931Feb 25: 931Feb 25Mar 25: 1,431Mar 25: 1,431Mar 25Apr 25: 1,156Apr 25: 1,156Apr 25May 25: 271May 25: 271May 25Jun 25: 116Jun 25: 116Jun 25Jul 25: 717Jul 25: 717Jul 25Aug 25: 361Aug 25: 361Aug 25Sep 25: 104Sep 25: 104Sep 25Oct 25: 193Oct 25: 193Oct 25Nov 25: 328Nov 25: 328328Nov 25
Contracts awarded per month
05001K1.5KNov 24: 386Nov 24: 386Nov 24Dec 24: 1,212Dec 24: 1,212Dec 24Jan 25: 1,017Jan 25: 1,017Jan 25Feb 25: 1,143Feb 25: 1,143Feb 25Mar 25: 1,418Mar 25: 1,418Mar 25Apr 25: 971Apr 25: 971Apr 25May 25: 117May 25: 117May 25Jun 25: 123Jun 25: 123Jun 25Jul 25: 736Jul 25: 736Jul 25Aug 25: 225Aug 25: 225Aug 25Sep 25: 127Sep 25: 127Sep 25Oct 25: 194Oct 25: 194Oct 25Nov 25: 317Nov 25: 317317Nov 25

The highlighted bar is November 2025. Hover a bar for its figure; the table below has every value.

FigureNovember 2025October 2025ChangeNovember 2024Change
Tenders published328193+70%230+43%
Estimated value€348,000€6,290,455-94%€5,300,695-93%
Buyers24240%23+4%
Contracts awarded317194+63%386-18%
Contract value (awarded)€2,647,343€4,684,408-43%€2,036,508+30%
Winners5444+23%50+8%
Bids per contract11.413.4—11.4—
Single-bid contracts9%15%—3%—

Buyers with the most tenders

Companies with the most contracts

Where the tenders were

  • Grande Lisboa 1

Procedures

  • not stated 327
  • Restricted procedure 1

Download the figures (CSV)

The report's aggregates: the figures, the comparisons and the top lists by name and count.

All reports: Oncology and immunomodulating drugs

Questions and answers

How many oncology drug tenders were published in Portugal in November 2025?
328 (by 24 buyers); for comparison, October 2025: 193, November 2024: 230.
Who won the most oncology drug tenders in Portugal in November 2025?
By number of contracts: Generis – Farmaceutica, S.A. (22), Teva Pharma - Produtos Farmaceuticos,lda (16), Novartis Farma-Prod.farmacêuticos,sa. (13), Merck Sharp Dohme (12) and Bristol - Myers Squibb Sa. (12); 54 companies won contracts in all.
Which buyers published the most oncology drug tenders in November 2025?
Unidade Local de Saúde de Trás-os-Montes e Alto Douro, E. P. E. (45), Unidade Local de Saúde de Santo António, E. P. E. (26), Unidade Local de Saúde da Região de Aveiro, E. P. E. (20), Unidade Local de Saúde de Viseu Dão-Lafões, E. P. E. (18) and Unidade Local de Saúde de Santa Maria, E. P. E. (17).
How competitive were oncology drug tenders in Portugal in November 2025?
On average 11.4 bids per contract (132 contracts with a known number of bids); 9% of contracts had a single bid.
What were the contracts worth in November 2025?
€2,647,343 (awarded value, 317 contracts); median about €230,000.

How the report is made

Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.